Sonavex

Baltimore, United States

Sonavex is a developer of an imaging technology designed to visualize and quantify critical data to detect anastomotic blood clots.

$15.0M raised

Oct 2024

Series A

Top Investors

National Science FoundationGaingelsTEDCOFusion FundNational Institutes of Health

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Sonavex raised?

Sonavex has raised $15.0M in total funding. The most recent round was Series A. The last funding was announced in October 2024.

Who are Sonavex's investors?

Sonavex's investors include National Science Foundation, Gaingels, TEDCO, Fusion Fund, National Institutes of Health.

Where is Sonavex headquartered?

Sonavex is headquartered in Baltimore, United States.

What does Sonavex do?

Sonavex is a developer of an imaging technology designed to visualize and quantify critical data to detect anastomotic blood clots.

What stage is Sonavex at?

Sonavex is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 24, 2024.

MLA

"Sonavex — Funding & Investors." VCBacked, October 24, 2024, https://www.vcbacked.co/company/sonavex. Accessed June 4, 2026.

APA

VCBacked. (2024). Sonavex — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/sonavex

Wikipedia (cite web)

{{cite web |title=Sonavex — Funding & Investors |url=https://www.vcbacked.co/company/sonavex |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 24, 2024.